$3.82
-0.12-3.05%
At close: -
$3.84
0.020.52%
After Hours: 5:16 PM EDT
Comments
Loading...
Kazia Therapeutics (KZIA) Forecast
NewsEarningsKazia Therapeutics (KZIA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Kazia Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:KZIA | Benzinga
Explore Kazia Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for KZIA.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Kazia Therapeutics (KZIA) stock?
You can purchase shares of Kazia Therapeutics (NASDAQ:KZIA) through any online brokerage.
Who are Kazia Therapeutics (KZIA) competitors?
Other companies in Kazia Therapeutics’s space includes: Curis (NASDAQ:CRIS), Nanoviricides (AMEX:NNVC), GlycoMimetics (NASDAQ:GLYC), CollPlant Biotechnologies (NASDAQ:CLGN) and Longeveron (NASDAQ:LGVN).
What is the forecast, or price target, for Kazia Therapeutics (KZIA) stock?
Kazia Therapeutics has a consensus price target of $2.50.
What is the current price for Kazia Therapeutics (KZIA)?
The stock price for Kazia Therapeutics (NASDAQ: KZIA) is $3.84 last updated May 2, 2025 at 5:16 PM EDT.
Does Kazia Therapeutics (KZIA) pay a dividend?
There are no upcoming dividends for Kazia Therapeutics.
When is Kazia Therapeutics (NASDAQ:KZIA) reporting earnings?
Kazia Therapeutics’s H1 earnings are confirmed for Friday, May 16, 2025.
Is Kazia Therapeutics (KZIA) going to split?
There is no upcoming split for Kazia Therapeutics.
What sector and industry does Kazia Therapeutics (KZIA) operate in?
Kazia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
